This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Dupilumab (Dupixent, Sanofi & Regeneron) may boost height in kids with severe atopic dermatitis (AD), according to a late-breaking abstract presented at Maui Derm Hawaii 2025. Cyr, PhD, Senior Director of Medical Affairs at Regeneron Pharmaceuticals, received the best poster Akamai Award at the meeting.
Johnson & Johnson has entered into an exclusive licensing agreement for the global development, manufacturing and commercialization of a STAT6 program for autoimmune and allergic diseases, including atopic dermatitis (AD), from Kaken Pharmaceutical.
Alexis and Kwatra “Seborrheic Dermatitis in Skin of Color” with Drs. The 20th Annual SOCS Scientific Symposium was generously supported by the following sponsors: AbbVie, Johnson & Johnson, Sanofi and Regeneron Pharmaceuticals, Inc. Adotama and Luke “A Fresh Look at Aging” with Drs.
Shared-decision making focused on weighing risks versus benefits is key when choosing the most appropriate systemic atopic dermatitis (AD) treatment for a patient, according to new research presented at the 2024 American Academy of Allergy, Asthma & Immunology (AAAAI) Annual Meeting in Washington, DC.
Incyte filed a lawsuit to try to block the launch of deuruxolitinib, claiming that it infringed on a patent on the use of ruxolitinib (Opzelura), which is approved for atopic dermatitis and vitiligo. Sun Pharma acquired deuruxolitinib when it purchased Concert Pharmaceuticals in March 2023 and received the U.S,
Dupilumab (Dupixent, Regeneron Pharmaceuticals, Inc., New systemic agents and even new concepts in the prevention of atopic dermatitis and the microbiome seem just around the corner too, Dr. Lio says. “We Food and Drug Administration (FDA) recently OKed a label update for dupilumab (Dupixent, Regeneron Pharmaceuticals, Inc.,
Aslan and Zenyaku are teaming up to explore how eblasakimab’s mechanism of action differs from that of other biologic therapies for atopic dermatitis (AD).
Silverberg, MD Molluscum Contagiosum appears to be on the rise and often travels with atopic dermatitis (AD). Topical isotretinoin, even when covering 90% of a patient’s body surface area, showed minimal systemic absorption. Watch Now The Lowdown on Molluscum Nanette B. Watch Now Biosimilars in Dermatology: Where Do They Fit in?
Dr Bhutani presents the case of a 15-year-old female with long standing atopic dermatitis and discusses the importance of balancing parental preferences for "natural" agents with effective pharmaceutical options.
Food and Drug Administration (FDA) has updated the label for dupilumab (Dupixent, Regeneron Pharmaceuticals, Inc. and Sanofi), adding efficacy and safety data for people aged 12 years and older with atopic dermatitis (AD) and uncontrolled moderate-to-severe hand and/or foot involvement. and Sanofi report. “We
The Ministry of Health, Labor and Welfare (MHLW) in Japan has granted marketing and manufacturing authorization for dupilumab (Dupixent, Sanofi and Regeneron Pharmaceuticals, Inc.) and Novartis Pharmaceuticals). Japan is the first country to approve dupilumab for CSU. This study met the primary and all key secondary endpoints.
Atopic dermatitis (AD) patients who switched to upadacitinib (Rinvoq, AbbVie) from dupilumab (Dupixent, Regeneron, and Sanofi) hit higher treatment targets, according to results from Period 2 of the LEVEL UP study. The most frequently reported TEAEs included nasopharyngitis, acne, upper respiratory tract infection, and atopic dermatitis.
Adult atopic dermatitis (AD) patients previously treated with dupilumab (Dupixent, Regeneron and Sanofi) who received 400mg eblasakimab weekly achieved Eczema Area Severity Index (EASI) 90, and 66.7% achieved a Validated Investigator Global Assessment (vIGA) score of 0 or 1 after 16 weeks compared to 14.3%
Silverberg, MD Molluscum Contagiosum appears to be on the rise and often travels with atopic dermatitis (AD). Topical isotretinoin, even when covering 90% of a patient’s body surface area, showed minimal systemic absorption. Watch Now The Lowdown on Molluscum Nanette B. Watch Now Biosimilars in Dermatology: Where Do They Fit in?
Dandruff (Seborrheic Dermatitis) Dandruff, medically known as seborrheic dermatitis , is a common scalp condition marked by excessive shedding of skin cells. Skin Conditions (Eczema, Psoriasis, Contact Dermatitis) as Causes of Dry, Itchy Scalp Various skin conditions can lead to a dry, itchy scalp: a.
Atopic dermatitis (AD) is extremely common, but it can resemble psoriasis, urticaria, non-blistering immunobolus disease, cutaneous lymphoma, and many other skin conditions. Silverberg, MD Molluscum Contagiosum appears to be on the rise and often travels with atopic dermatitis (AD). Watch Now The Lowdown on Molluscum Nanette B.
Silverberg, MD Molluscum Contagiosum appears to be on the rise and often travels with atopic dermatitis (AD). Topical isotretinoin, even when covering 90% of a patient’s body surface area, showed minimal systemic absorption. Watch Now The Lowdown on Molluscum Nanette B. Watch Now Biosimilars in Dermatology: Where Do They Fit in?
Silverberg, MD Molluscum Contagiosum appears to be on the rise and often travels with atopic dermatitis (AD). Topical isotretinoin, even when covering 90% of a patient’s body surface area, showed minimal systemic absorption. Watch Now The Lowdown on Molluscum Nanette B. Watch Now Biosimilars in Dermatology: Where Do They Fit in?
Silverberg, MD Molluscum Contagiosum appears to be on the rise and often travels with atopic dermatitis (AD). Topical isotretinoin, even when covering 90% of a patient’s body surface area, showed minimal systemic absorption. Watch Now The Lowdown on Molluscum Nanette B. Watch Now Biosimilars in Dermatology: Where Do They Fit in?
Every pharmaceutical and skincare company worth their while has a retinol-containing product in the range, and often multiple formulations. Thus, for people suffering from sensitive skin, contact dermatitis, rosacea, and other such conditions, bakuchiol may well be the only anti-aging alternative available.
Genodermatoses can masquerade as atopic dermatitis (AD). Raj Chovatiya, MD, PhD Atopic dermatitis (AD) is extremely common, but it can resemble psoriasis, urticaria, non-blistering immunobolus disease, cutaneous lymphoma, and many other skin conditions. Watch Now Think Twice: Is It Really AD?
Raj Chovatiya, MD, PhD Atopic dermatitis (AD) is extremely common, but it can resemble psoriasis, urticaria, non-blistering immunobolus disease, cutaneous lymphoma, and many other skin conditions. Silverberg, MD Molluscum Contagiosum appears to be on the rise and often travels with atopic dermatitis (AD).
Raj Chovatiya, MD, PhD Atopic dermatitis (AD) is extremely common, but it can resemble psoriasis, urticaria, non-blistering immunobolus disease, cutaneous lymphoma, and many other skin conditions. Watch Now Pro Pearls for Diagnosing Genodermatoses Elizabeth Swanson, MD Genodermatoses can masquerade as atopic dermatitis (AD).
Raj Chovatiya, MD, PhD Atopic dermatitis (AD) is extremely common, but it can resemble psoriasis, urticaria, non-blistering immunobolus disease, cutaneous lymphoma, and many other skin conditions. Watch Now Pro Pearls for Diagnosing Genodermatoses Elizabeth Swanson, MD Genodermatoses can masquerade as atopic dermatitis (AD).
In this era of readily available pharmaceutical products for every imaginable ailment, it can be easy to default to the drug store when we need relief. Medieval Persian pharmaceutical manuscripts refer to 1200 types of oxymel. It has not always been that way. Reposted from: [link]
Watch Now [the_ad id="9263"] [the_ad id="9265"] Pro Pearls for Diagnosing Genodermatoses Elizabeth Swanson, MD Genodermatoses can masquerade as atopic dermatitis (AD). Silverberg, MD Molluscum Contagiosum appears to be on the rise and often travels with atopic dermatitis (AD). Watch Now The Lowdown on Molluscum Nanette B.
Watch Now [the_ad id="9263"] [the_ad id="9265"] Pro Pearls for Diagnosing Genodermatoses Elizabeth Swanson, MD Genodermatoses can masquerade as atopic dermatitis (AD). Silverberg, MD Molluscum Contagiosum appears to be on the rise and often travels with atopic dermatitis (AD). Watch Now The Lowdown on Molluscum Nanette B.
Watch Now [the_ad id="9263"] [the_ad id="9265"] Pro Pearls for Diagnosing Genodermatoses Elizabeth Swanson, MD Genodermatoses can masquerade as atopic dermatitis (AD). Silverberg, MD Molluscum Contagiosum appears to be on the rise and often travels with atopic dermatitis (AD). Watch Now The Lowdown on Molluscum Nanette B.
Moisturize your skin : Retinoids can cause dryness and irritation (retinoid dermatitis). Pharmaceutics. It’s best to avoid using them with other sources of irritation, like benzoyl peroxide, salicylic acid, alpha hydroxy acids, scrubs, and exfoliators. Using a moisturizer can help. Clinical Interventions in Aging. 2006;1(4):327-348.
Raj Chovatiya, MD, PhD Atopic dermatitis (AD) is extremely common, but it can resemble psoriasis, urticaria, non-blistering immunobolus disease, cutaneous lymphoma, and many other skin conditions. Silverberg, MD Molluscum Contagiosum appears to be on the rise and often travels with atopic dermatitis (AD).
Raj Chovatiya, MD, PhD Atopic dermatitis (AD) is extremely common, but it can resemble psoriasis, urticaria, non-blistering immunobolus disease, cutaneous lymphoma, and many other skin conditions. Silverberg, MD Molluscum Contagiosum appears to be on the rise and often travels with atopic dermatitis (AD).
Rubin and Brod penned in September 2019 that dermatologists are seeing both irritant and allergic contact dermatitis and photosensitization from plant extracts in products. That being said, I did find lots of papers about castor oil and its derivatives to cause dermatitis on the skin. We can’t forget the JAMA editorial that Drs.
AD: New topicals for kids “The most exciting new research is in the realm of topical therapies for atopic dermatitis (AD) in children,” shares Peter A. Food and Drug Administration (FDA) approval of Verrica Pharmaceuticals Inc’s Ycanth for molluscum contagiosum, which is delivered through a single-use applicator.
AD: New topicals for kids “The most exciting new research is in the realm of topical therapies for atopic dermatitis (AD) in children,” shares Peter A. Food and Drug Administration (FDA) approval of Verrica Pharmaceuticals Inc’s Ycanth for molluscum contagiosum, which is delivered through a single-use applicator.
Here’s a review of 10 natural antimicrobials you can reach for as a first line of defense, before resorting to a pharmaceutical antibiotic. The good news is there are many natural plant-based remedies that will help kill bacteria without the risk of building resistance.
Alys Pharmaceuticals, Inc. Alys combines six asset-centric Medicxi companies including Al Aldena Therapeutics, Graegis Pharmaceuticals, Granular Therapeutics, Klirna Biotech, Nira Biosciences and Vimela Therapeutics. ” The post Get to Know Alys Pharmaceuticals, Inc. appeared first on The Dermatology Digest.
3 The Phototherapy “Laundry List” Pharmaceuticals are changing the landscape for some major diagnoses but there’s a whole host of diagnoses that Dr. Richard said she considers the “laundry list” that still very much utilizes and depends on phototherapy treatment.
We organize all of the trending information in your field so you don't have to. Join 5,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content